France In Talks With BeNeLuxA Access To Meds Coalition; Group Plans Expansion Beyond EU
Executive Summary
The BeNeLuxA collaboration for sustainable access to medicines may soon expand further. Future partners could include France and non-EU markets.
You may also be interested in...
Is Dutch Govt Pursuing Wider EU Discussion And Collaboration On Pricing and Reimbursement?
An initiative from the Netherlands to ensure that pharmaceutical companies market centrally approved medicines in all EU member states is probably intended to fuel discussions on the differences in national pricing and reimbursement policies, says a legal expert.
Is Europe’s BeNeLuxA Coalition Moving Too Fast?
The BeNeLuxA initiative for improving access to medicines could soon include more countries, but much about the collaboration remains opaque for the pharmaceutical industry. Lawyer Koosje van Lessen Kloeke says constructive dialogue between the initiative and industry would benefit the collaboration.
EU Supplementary Protection Certificate Mechanism Needs To Go, Say Campaigners
A group of more than 30 NGOs has urged the European Commission to consider abolishing the system of granting supplementary protection certificates to pharmaceutical companies, saying it delays generic competition and affects the availability of affordable medicines. A UK-based patent attorney, however, says the assertions made by the NGOs are not supported by the evidence.